Kaiser Permanente-Medical Group

San Diego, California 92120

0 studies enrolling now · 11 studies all time

What they study most

B-cell Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin's, Malignant Melanoma, Metastases, Metastatic Androgen Independent Prostate Cancer, Metastatic Colorectal Cancer, Multiple Myeloma, Overactive Bladder, Prostate Cancer, Renal Cell Carcinoma, Triple Negative Breast Cancer, Urgency Urinary Incontinence

Studies at this site

• Reduced-dose Botox for Urgency Incontinence Among Elder Females — Running, not enrolling
• Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo — Running, not enrolling
• Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442) — Completed
• Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status — Status unconfirmed
• A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy — Completed
• A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma — Completed
• A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma — Completed
• Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy — Completed
• Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma — Completed
• Vaccine Therapy for Patients With Stage III Melanoma — Status unconfirmed
• Vaccine Therapy for Patients With Stage IV Melanoma — Status unconfirmed